Dr. Hsiang-Hsuan Michael Yu, MD

Dr. Yu practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Yu's NPI, 1740386358, was assigned on September 15, 2006. Dr. Yu graduated from Rutgers Robert Wood Johnson Medical School in 2001. Dr. Yu holds Florida license ME100434.

Dr. Yu's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Yu's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Yu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yu practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Yu's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Yu is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Yu's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Yu treats.

CMS data shows 3,377 Medicare services from Dr. Yu across 21 procedure codes in 2024, for 628 Medicare patients. Medicare paid $216,113 for them.

CMS counts 628 Medicare patients who saw Dr. Yu in 2024. The largest group is 65 to 74, with 328 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yu's median patient age at 67, with 49% women.

In 2024, Dr. Yu wrote 228 Medicare Part D claims for 104 patients. 99% of them were for generic drugs. CMS names the drug for 167 of them, across 5 drugs with 11 or more claims each, at $1,367 in total drug cost. In 2023, CMS named 54 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Yu for performance year 2024, reported as part of a group. Dr. Yu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yu as offering telehealth.

Dmand AI links 45 papers to Dr. Yu, published from 2010 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Radiosurgery and Breast Neoplasms. Dr. Yu has published most often in J Neurooncol. Dr. Yu's most frequent co-authors are Kamran Ali Ahmed, MD, Arnold Besohong Etame, MD and Peter A. Forsyth, MD.

CMS Open Payments shows 86 general payments to Dr. Yu from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Novocure Inc. paid the most, $14,947.

Dr. Yu graduated from Rutgers Robert Wood Johnson Medical School in 2001.

Dr. Yu is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.